- Filed
- May 18, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 91.75M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 91.75M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 91.75M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $2.57M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$333.36K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.69M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $125.35K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.45M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.9M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.61M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.07M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.57M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.09M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.07M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.59M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.02 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $603.04K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $496.46K |
| Net Income | Q1 2026 · Mar 31, 2026 | $1.94M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$290.86K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$464.47K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$275.52K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $138.57K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $220.94K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $441.5K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $712.39K |